The semi-naturalistic study found ‘no notable evidence of driving impairment’ after dosing prescribed cannabis products.
New research adds to the evidence base for the use of cannabis in chronic pain, Tourette's, Parkinson's, PTSD and lung cancer.
The government's 'lack of understanding' and ‘predictably poor’ response has been criticised.
A new range of CBD products brings innovation back to the sector in a post-novel foods world.
It is thought to be the world's first trial of its kind into medicinal cannabis and endometriosis.
We take a look at the meaning behind 420 and reflect on the moves towards reform across Europe.
Reports include patients being labelled as ‘drug addicts’, refused help and referred to social services after disclosing that they use cannabis medicinally.
An increase in self-medicating, further reluctance to prescribe and a potential post code lottery, but overall freedom from stigma and fear?
Draft proposals to be debated in parliament this month are expected to include a 5g daily limit and a compulsory register of consumers.
Following a 'positive' inaugural meeting, concerns remain over the appointment of the Advisory Support Group.
Two companies in the UK CBD and wellness industry will drive to Kyiv distributing CBD and adaptogenic supplements to Non-Government Organisations (NGOs), charities and media teams...